Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29269 | 189 | 19.3 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
29269 | 1 | TEMOCILLIN//CEFROXADINE//BOLUS FOOD | 189 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TEMOCILLIN | authKW | 623162 | 5% | 43% | 9 |
2 | CEFROXADINE | authKW | 207721 | 2% | 43% | 3 |
3 | BOLUS FOOD | authKW | 161563 | 1% | 100% | 1 |
4 | COST OF ANTIMICROBIAL THERAPY | authKW | 161563 | 1% | 100% | 1 |
5 | COST OF NOSOCOMIAL INFECTIONS | authKW | 161563 | 1% | 100% | 1 |
6 | EMERGENCE ISTANCE BACTERIENNE IN VIVO EA 3964 | address | 161563 | 1% | 100% | 1 |
7 | TEMOCILLIN HYDROLYSIS | authKW | 161563 | 1% | 100% | 1 |
8 | TEMOCILLIN ISOMERS | authKW | 161563 | 1% | 100% | 1 |
9 | TEMOCILLIN STABILITY | authKW | 161563 | 1% | 100% | 1 |
10 | UNITE HYG HOSPITALIERE MICROBIOL | address | 161563 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2262 | 63% | 0% | 119 |
2 | Toxicology | 1113 | 23% | 0% | 44 |
3 | Infectious Diseases | 615 | 17% | 0% | 33 |
4 | Microbiology | 603 | 24% | 0% | 46 |
5 | Medicine, General & Internal | 113 | 13% | 0% | 24 |
6 | Gastroenterology & Hepatology | 33 | 5% | 0% | 9 |
7 | Oncology | 19 | 7% | 0% | 14 |
8 | Pathology | 14 | 3% | 0% | 6 |
9 | Medicine, Research & Experimental | 5 | 3% | 0% | 6 |
10 | Medical Laboratory Technology | 4 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EMERGENCE ISTANCE BACTERIENNE IN VIVO EA 3964 | 161563 | 1% | 100% | 1 |
2 | UNITE HYG HOSPITALIERE MICROBIOL | 161563 | 1% | 100% | 1 |
3 | AFDELING MED MICROBIOL INFECTIEZIEKTEN | 80781 | 1% | 50% | 1 |
4 | ASHFORD ST PETERS HOSP | 80781 | 1% | 50% | 1 |
5 | P OFF | 80781 | 1% | 50% | 1 |
6 | DIENST INTENSIEVE ZORGEN | 53853 | 1% | 33% | 1 |
7 | NEPHROL INFECT DIS | 24852 | 1% | 8% | 2 |
8 | CCLIN PARIS NORD | 23079 | 1% | 14% | 1 |
9 | CLIN PHARM GRP | 22281 | 1% | 7% | 2 |
10 | ROYAL BERKSHIRE HOSP | 16155 | 1% | 10% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUGS | 39543 | 20% | 1% | 37 |
2 | CHEMOTHERAPY-TOKYO | 21590 | 3% | 3% | 5 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 5706 | 11% | 0% | 21 |
4 | INTERNATIONAL JOURNAL OF BIOLOGICAL RESEARCH IN PREGNANCY | 5210 | 1% | 3% | 1 |
5 | ACTA PHARMACOLOGICA ET TOXICOLOGICA | 3552 | 3% | 0% | 5 |
6 | CHEMOTHERAPY | 2287 | 3% | 0% | 6 |
7 | JOURNAL DES ANTI-INFECTIEUX | 2181 | 1% | 1% | 1 |
8 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1972 | 2% | 0% | 3 |
9 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1737 | 8% | 0% | 16 |
10 | CRC CRITICAL REVIEWS IN TOXICOLOGY | 1367 | 1% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TEMOCILLIN | 623162 | 5% | 43% | 9 | Search TEMOCILLIN | Search TEMOCILLIN |
2 | CEFROXADINE | 207721 | 2% | 43% | 3 | Search CEFROXADINE | Search CEFROXADINE |
3 | BOLUS FOOD | 161563 | 1% | 100% | 1 | Search BOLUS+FOOD | Search BOLUS+FOOD |
4 | COST OF ANTIMICROBIAL THERAPY | 161563 | 1% | 100% | 1 | Search COST+OF+ANTIMICROBIAL+THERAPY | Search COST+OF+ANTIMICROBIAL+THERAPY |
5 | COST OF NOSOCOMIAL INFECTIONS | 161563 | 1% | 100% | 1 | Search COST+OF+NOSOCOMIAL+INFECTIONS | Search COST+OF+NOSOCOMIAL+INFECTIONS |
6 | TEMOCILLIN HYDROLYSIS | 161563 | 1% | 100% | 1 | Search TEMOCILLIN+HYDROLYSIS | Search TEMOCILLIN+HYDROLYSIS |
7 | TEMOCILLIN ISOMERS | 161563 | 1% | 100% | 1 | Search TEMOCILLIN+ISOMERS | Search TEMOCILLIN+ISOMERS |
8 | TEMOCILLIN STABILITY | 161563 | 1% | 100% | 1 | Search TEMOCILLIN+STABILITY | Search TEMOCILLIN+STABILITY |
9 | PRIMARY LIVER CELL CARCINOMA | 80781 | 1% | 50% | 1 | Search PRIMARY+LIVER+CELL+CARCINOMA | Search PRIMARY+LIVER+CELL+CARCINOMA |
10 | DEXAMETHASONE SUPPRESSION TESTS | 53853 | 1% | 33% | 1 | Search DEXAMETHASONE+SUPPRESSION+TESTS | Search DEXAMETHASONE+SUPPRESSION+TESTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOUBIROU, JF , (2013) FOCUS: TEMOCILLIN, A CARBAPENEM ALTERNATIVE TO TREAT INFECTIONS DUE TO C3G RESISTANT ENTEROBACTERIACEAE?.JOURNAL DES ANTI-INFECTIEUX. VOL. 15. ISSUE 2. P. 60 -70 | 39 | 75% | 1 |
2 | LIVERMORE, DM , TULKENS, PM , (2009) TEMOCILLIN REVIVED.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 63. ISSUE 2. P. 243 -245 | 19 | 59% | 39 |
3 | KENT, L , BRADLEY, JM , FRANCE, M , DORING, G , CARRYN, S , BRADBURY, I , RENDALL, J , JONES, A , ELBORN, JS , (2008) TEMOCILLIN IN CYSTIC FIBROSIS: A RETROSPECTIVE PILOT STUDY.JOURNAL OF CYSTIC FIBROSIS. VOL. 7. ISSUE 6. P. 551-554 | 14 | 74% | 5 |
4 | KANG, YS , LEE, SY , KIM, NH , CHOI, HM , PARK, JS , KIM, W , LEE, HJ , (2006) A SPECIFIC AND RAPID HPLC ASSAY FOR THE DETERMINATION OF CEFROXADINE IN HUMAN PLASMA AND ITS APPLICATION TO PHARMACOKINETIC STUDY IN KOREAN.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 40. ISSUE 2. P. 369-374 | 8 | 80% | 6 |
5 | SPENCER, RC , (1990) TEMOCILLIN.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 26. ISSUE 6. P. 735-737 | 11 | 79% | 7 |
6 | RODRIGUEZ-VILLALOBOS, H , MALAVIOLLE, V , FRANKARD, J , DE MENDONCA, R , NONHOFF, C , STRUELENS, MJ , (2006) IN VITRO ACTIVITY OF TEMOCILLIN AGAINST EXTENDED SPECTRUM BETA-LACTAMASE-PRODUCING ESCHERICHIA COLI.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 57. ISSUE 4. P. 771-774 | 7 | 64% | 31 |
7 | MARTINEZBELTRAN, J , LOZA, E , GOMEZALFEREZ, A , ROMEROVIVAS, J , BOUZA, E , (1985) TEMOCILLIN - INVITRO ACTIVITY COMPARED WITH OTHER ANTIBIOTICS.DRUGS. VOL. 29. ISSUE . P. 91-97 | 11 | 100% | 2 |
8 | OVERBOSCH, D , VANGULPEN, C , MATTIE, H , (1985) RENAL CLEARANCE OF TEMOCILLIN IN VOLUNTEERS.DRUGS. VOL. 29. ISSUE . P. 128-134 | 12 | 86% | 7 |
9 | SOUBIROU, JF , ROSSI, B , COUFFIGNAL, C , RUPPE, E , CHAU, F , MASSIAS, L , LEPEULE, R , MENTRE, F , FANTIN, B , (2015) ACTIVITY OF TEMOCILLIN IN A MURINE MODEL OF URINARY TRACT INFECTION DUE TO ESCHERICHIA COLI PRODUCING OR NOT PRODUCING THE ESBL CTX-M-15.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 70. ISSUE 5. P. 1466 -1472 | 7 | 35% | 3 |
10 | GLUPCZYNSKI, Y , HUANG, TD , BERHIN, C , CLAEYS, G , DELMEE, M , IDE, L , IEVEN, G , PIERARD, D , RODRIGUEZ-VILLALOBOS, H , STRUELENS, M , ET AL (2007) IN VITRO ACTIVITY OF TEMOCILLIN AGAINST PREVALENT EXTENDED-SPECTRUM BETA-LACTAMASES PRODUCING ENTEROBACTERIACEAE FROM BELGIAN INTENSIVE CARE UNITS.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 26. ISSUE 11. P. 777 -783 | 6 | 50% | 18 |
Classes with closest relation at Level 1 |